What departments does Nabriva Therapeutics plc have?

Nabriva Therapeutics plc has employees across 4 departments including Finance, Accounting, Business, Sales.

What is the largest department at Nabriva Therapeutics plc?

The largest department at Nabriva Therapeutics plc is Business with 5 employees.

Where are Nabriva Therapeutics plc employees located globally?

Nabriva Therapeutics plc has employees across 2 continents and 5 countries including Austria, Ireland, Germany, Croatia, United States Of America.

How has Nabriva Therapeutics plc's team size changed over time?

Nabriva Therapeutics plc's team has decreased from approximately 79 to 20 employees based on available data.

Nabriva Therapeutics plc Employee Directory

Q: Who are Nabriva Therapeutics plc's key employees and leadership?

Nabriva Therapeutics plc's key employees include: Executive Assistant To Cfo, Cco And Cio: C. R., Chief Executive Officer, Nabriva Therapeutics: J. J., Chief Medical Officer: D. M., Vice President - Commercial Excellence: T. M..

Biotechnology ResearchDublin, Ireland11-50 Employees

Nabriva Therapeutics plc is a commercial-stage biotechnology company focused on developing novel antibiotics to treat serious infections. It is headquartered in Dublin, Ireland, with offices and laboratories in Vienna, Austria and King of Prussia, Pennsylvania, and additional locations in San Diego, California, United States. The company markets Xenleta (lefamulin), approved by the FDA for oral and intravenous use, and CONTEPO (fosfomycin) for injection, for which a US NDA has been submitted for complicated urinary tract infections including acute pyelonephritis. Recent strategic actions include the sale of Contepo assets to Meitheal Pharmaceuticals in July 2024 and prior asset divestitures such as Xenleta assets transferred to Sumitomo Pharma in 2023, with an earlier Merck collaboration in 2020 to market SIVEXTRO. The organization employs between 11 and 50 people.

Nabriva Therapeutics plc Global Highlights

North America
31

United States Of America
31

Europe
18

Ireland
15
Austria
1
Germany
1
Croatia
1

Nabriva Therapeutics plc's Leadership

J. J.
Chief Executive Officer, Nabriva Therapeutics
Mobile Phone
Email
D. M.
Chief Medical Officer
Mobile Phone
Email
T. M.
Vice President - Commercial Excellence
Mobile Phone
Email
C. R.
Executive Assistant To Cfo, Cco And Cio
Mobile Phone
Email
C. B.
Executive Assistant To Chief Executive Officer
Mobile Phone
Email
M. M.
Vice President, Regulatory Affairs
Mobile Phone
Email
W. S.
Vice President, Commercial Strategy
Mobile Phone
Email
D. C.
Director, National Accounts, Market Access
Mobile Phone
Email

Nabriva Therapeutics plc Employee Metrics

100%

50%

0%

2026

2025

Business
Sales
Accounting
Finance
Human Resources
Other
Research
Pharmaceuticals
Administrative
Community & Social Services
Biotechnology
Entrepreneurship

Contact profiles from Nabriva Therapeutics plc

Name

Title

Contact Info

Location

Last Update

C. R.
Executive Assistant To Cfo, Cco And Cio
Mobile Phone
Email
Feb 24, 2024
D. M.
Chief Medical Officer
Mobile Phone
Email
Oct 23, 2024
J. J.
Chief Executive Officer, Nabriva Therapeutics
Mobile Phone
Email
Oct 23, 2024
C. B.
Executive Assistant To Chief Executive Officer
Mobile Phone
Email
United StatesPennsylvania
Feb 05, 2026
M. M.
Vice President, Regulatory Affairs
Mobile Phone
Email
United StatesPennsylvania
Feb 03, 2025
T. M.
Vice President - Commercial Excellence
Mobile Phone
Email
Oct 04, 2023
W. S.
Vice President, Commercial Strategy
Mobile Phone
Email
United StatesPennsylvania
D. C.
Director, National Accounts, Market Access
Mobile Phone
Email
United StatesNew York
Mar 25, 2026
B. F.
Senior Director, Financial Reporting & Compliance, Treasurer - U.S
Mobile Phone
Email
United StatesPennsylvania
Mar 25, 2026
F. A.
Director, Customer Insights And Commerciasl Forecasting
Mobile Phone
Email
United StatesPennsylvania
Mar 04, 2026

Frequently Asked Questions

What is Nabriva Therapeutics plc known for?

Nabriva Therapeutics plc was founded in 2006 operates in the Biotechnology Research industry. The company's main headquarters is located in 25-28 North Wall Quay Dublin, Dublin Ireland; you can contact the main corporate office by phone at

+43-4301-74****

. Explore Nabriva Therapeutics plc's company overview page for more information.

What is Nabriva Therapeutics plc's most common email format?

Nabriva Therapeutics plc employees' email format typically follows the pattern of . Trying to find reliable and up-to-date employee contact data? Find more Nabriva Therapeutics plc email formats with LeadIQ.

How many employees does Nabriva Therapeutics plc have currently?

Nabriva Therapeutics plc has approximately 25 employees as of May 2026. These team members are located across 2 continents, including North AmericaEurope.

Who are Nabriva Therapeutics plc's key employees and leadership?

As of May 2026, Nabriva Therapeutics plc's key employees include:

Chief Executive Officer, Nabriva Therapeutics: J. J.
Chief Medical Officer: D. M.
Vice President - Commercial Excellence: T. M.
Executive Assistant To Cfo, Cco And Cio: C. R.
Executive Assistant To Chief Executive Officer: C. B.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

Everything for prospecting,
in one platform.

What you can expect from LeadIQ:

B2B data verified in real-time
Sync data to your CRM, & add it to an outreach sequence in one click
Integrations with your tech stack for optimal efficiency
A patented AI cold email generator
Account & contact-level job change tracking

Nabriva Therapeutics plc Employee Directory

Find Nabriva Therapeutics plc employees' phone numbers or email addresses

Name search is limited — try advanced search instead